CAMBRIDGE, Mass.-(BUSINESS WIRE) - Data from an observational phase IV study of 499 patients entitled The Swiss MS Skin Project show that multiple sclerosis (MS) patients taking AVONEX (interferon ...
CAMBRIDGE, MA – Sept. 11, 2009 – Data from an observational phase IV study of 499 patients entitled The Swiss MS Skin Project show that multiple sclerosis (MS) patients taking AVONEX (interferon ...
FRANKFURT (Reuters) - Bayer's multiple sclerosis (MS) treatment Betaferon was shown to be more effective when given on the first sign of the disease than if treatment is delayed, the German drugmaker ...
Berlin, December 1, 2009 - Bayer Schering Pharma AG announced today that the Chinese State Food and Drug Administration (SFDA) has approved Betaferon® (interferon beta-1b) therapy for patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback